MED vs UTZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

MED

50.5
AI Score
VS
UTZ Wins

UTZ

52.7
AI Score

Investment Advisor Scores

MED

51score
Recommendation
HOLD

UTZ

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MED UTZ Winner
Revenue 152.43M 361.30M UTZ
Net Income -5.22M -1.70M UTZ
Gross Margin 69.0% 25.4% MED
Net Margin -3.4% -0.5% UTZ
Operating Income -7.62M 7.80M UTZ
ROE -2.7% -0.2% UTZ
ROA -2.0% -0.1% UTZ
Total Assets 260.40M 2.79B UTZ
Cash 71.91M 73.70M UTZ
Current Ratio 4.86 1.14 MED
Free Cash Flow -108,000 -26.00M MED

Relative Price Performance (Last 90 Days)

MED 1M: -11.1% · 3M: -10.7% UTZ 1M: +71.3% · 3M: +82.4%

Current Technical Phase

MED

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.7%), weak momentum, RSI 39

RSI (14): 38.7 · Price: $9.74

UTZ

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (17.6% over 20 days), RSI 87

RSI (14): 86.5 · Price: $14.17

Fundamentals Snapshot

Metric MED UTZ
Market Cap
Forward P/E -16.5 17.0
Trailing P/E
Revenue (TTM)
Revenue Growth -0.3% 0.0%
Gross Margin 0.7% 0.3%
Operating Margin -0.1% 0.0%
EPS -1.82 -0.10
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, UTZ is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.